Resumo

PERERA MINIET, Elianne et al. Dorzolamide for the treatment of cystoid macular edema after cataract surgery. Rev Cubana Oftalmol [online]. 2018, vol.31, n.1, pp. 82-89. ISSN 1561-3070.

ABSTRACT Macular cystic edema is one of the most prevalent postoperative complications after cataract surgery, leading in many cases to a decrease of postsurgical visual acuity in the patients. Due to the heterogeneity of diagnostic criteria, its incidence has been reported between 1 % and 30 %. With the objetive to show the results of the use of dorzolamide in the macular cystic edema after cataract surgery, we was carried out through searches in different publications related to the specialty, using data from leading ophthalmology journals, from the last 10 years. As the most frequent postoperative complication of cataract surgery, that can be translated with loss of postoperative vision, it is important to address aspects related to treatment and specifically the results of research that currently promote the use of topical carbonic anhydrase inhibitors. In this regard, dorzolamide has become important as a treatment option, with tangible results and few adverse effects compared with the systemic use of this group of drugs.

Palavras-chave : macular cystic edema; dorzolamide.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )